Eksempler på brug af Multocida på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
Bronchial infections caused by Pasteurella multocida.
Pasteurella multocida is the most common bacteria to cause skin infections.
Turkeys only- for the treatment of infections caused by Pasteurella multocida.
This bacterium is often present with Pasteurella multocida and makes the disease worse.
Infections of the respiratory tract caused by Escherichia coli, Salmonella spp.,Pasteurella multocida.
Infections of the respiratory tract caused by Pasteurella multocida, Actinobacillus pleuropneumoniae.
Strains of Escherichia coli,Pasteurella multocida, Mycoplasma gallisepticum isolated from broilers and turkeys have been shown to be sensitive to difloxacin.
Protein dO(non-toxic deletion derivative of Pasteurella multocida) dermonecrotic toxin.
Dermonecrotic toxin producing Pasteurella multocida is the pathogen responsible for turbinate atrophy in progressive atrophic rhinitis.
The main measure of effectiveness was the amount of antibodies to Bordetella bronchiseptica and also to Pasteurella multocida toxin.
Colonisation of the surface of the nasal mucosa by Pasteurella multocida is most often promoted by Bordetella bronchiseptica.
Zactran has been shown to be efficacious in the treatment and prevention of BRD, associated with Mannheimia haemolytica,Pasteurella multocida and Histophilus somni.
An active ingredient of Porcilis AR-T DF,Pasteurella multocida toxin, is produced by a method known as‘ recombinant technology.
For the second clinical study“ Efficacy of the doxycycline in feed for the control of pneumonia caused by P. multocida and Mycoplasma hyopneumoniae.
Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia and require specific medication.
Treatment of bacterial respiratory disease associated with Actinobacillus pleuropneumoniae,Pasteurella multocida, Haemophilus parasuis, and Streptococcus suis.
For the treatment of skin and soft tissue infections including pyoderma, wounds and abscesses associated with Staphylococcus intermedius, β-haemolytic Streptococci,Escherichia coli and/ or Pasteurella multocida.
The vaccine contains a non-toxic recombinant derivative of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.
The applicant conducted a pivotal controlled,randomized two-centred field trial using their final formulation to demonstrate efficacy for respiratory disease caused by P. multocida and B. bronchiseptica.
The broad spectrum antimicrobial activity of gamithromycin includes Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, the bacterial pathogens most commonly associated with BRD.
The Pasteurella multocida toxin is made by a bacterium cell that has received a gene(DNA), which makes it able to produce Pasteurella multocida toxoid, a genetically modified form of toxin which has adequate immunogenic activity and which is free from the toxic properties.
Cefovecin exhibits in-vitro activity against Staphylococcus intermedius and Pasteurella multocida which are associated with canine and feline skin infections.
It is used in cattle to treat or to prevent Bovine Respiratory Disease(BRD) caused by the bacteria Mannheimia haemolytica,Pasteurella multocida and Histophilus somni.
For the treatment andprevention of porcine respiratory disease caused by Pasteurella multocida and Bordetella bronchiseptica, susceptible to doxycycline, when the disease has been diagnosed in the herd.
In this study, blood was taken from piglets in each litter born from each sow, and tested for antibodies to Pasteurella multocida toxin and Bordetella bronchiseptica.
For the treatment and prevention of porcine respiratory disease caused by Pasteurella multocida and Bordetella bronchiseptica, susceptible to doxycycline, when the disease has been diagnosed in the herd.“.
The product is authorised with the indication the treatment of swine respiratory disease caused by Pasteurella multocida, Bordetella bronchiseptica and Mycoplasma hyopneumoniae.
Treatment and metaphylaxis of swine respiratory disease associated with Actinobacillus pleuropneumoniae,Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis and Bordetella bronchiseptica sensitive to tulathromycin.
When applying a proposed microbiological breakpoint of S≤ 2 µg/ ml, no resistance to cefovecin was detected in Pasteurella multocida and Fusobacterium spp. field isolates.
Porcilis AR-T DF contains a non-toxic recombinant derivative(see later)of the Pasteurella multocida toxin and also inactivated Bordetella bronchiseptica bacterial cells.